The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000604303
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
1/04/2026
Date registered
Help: Date registered
14/05/2026
Date last updated
Help: Date last updated
14/05/2026
Date data sharing statement initially provided
Help: Data sharing statement date
14/05/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
Plant-based and Animal-based Protein Diets on Muscle Growth and Functional Health in Overweight Elderly - Feasibility study (Phase 2)
Scientific title
PLANIMO - PLant-based and ANImal-based Protein-source Diets on Muscle Synthesis and Functional Health in Overweight Elderly - Feasibility study (Phase 2)
Additional trial identifiers [1] 315852 0
Nil known
Universal Trial Number (UTN)
Trial acronym
PLANIMO
Related trial records
ANZCTR Trial Id: ACTRN12625001351404 is Phase 1 of this study

Health condition
Health condition(s) studied:
Sarcopenia 339609 0
Condition category
Condition code
Musculoskeletal 335854 335854 0 0
Other muscular and skeletal disorders
Diet and Nutrition 335856 335856 0 0
Other diet and nutrition disorders
Metabolic and Endocrine 335857 335857 0 0
Normal metabolism and endocrine development and function
Cardiovascular 335858 335858 0 0
Normal development and function of the cardiovascular system

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
INTERVENTION GROUPS:
The intervention is a 14-day dietary intervention, with a total of 4 visits.
Visit 1 is a 1-hour phone call, including an explanation of all measures of the study.

Visit 2 is a physical visit to Deakin University. At this point, all the participants have been allocated to their intervention groups. At visit 2, all participants will receive dietary counselling as well as a 14-day dietary plan by a dietitian on how to follow an isocaloric diet providing 1-1.2g of protein per kg of body weight. The 14-day dietary plan includes a shopping list for all foods needed for the intervention, as well as ingredients and recipes for all meals of the entire 14 days. Participants do not receive any foods from the study.
All participants will receive two phone calls (on days 5 and 10 of the intervention) during the intervention from a dietitian in the team to ensure adherence to the diet. If any issues or dislikes occur with the diet, the team dietitian will adjust the diet. These adjustments include but are not limited to swapping out foods for foods that are better tolerated or liked, as well as potentially increasing or decreasing food volume, or spacing meals differently.
The study will involve three intervention groups, including a control group (Intervention Group C).

1. Intervention A: Will consume a diet with 100% plant-based protein sources.
2. Intervention B: Will consume a diet with 70% plant-based and 30% animal-based protein sources.
3. Intervention C (Control Group): Will consume a diet with 30% plant-based and 70% animal-based protein sources (closely resembling the current dietary protein distribution in Australia).

All the intervention groups will be supervised by dieticians who will tailor the diet to comply with the recommended daily nutrient intake. In addition, the diet will be aligned with the sensory needs and close to dietary habits, allowing a smooth behavioural transition. Examples of protein sources being used as plant protein are: legumes, nuts & seeds, vegetables, cereals and bread etc. Examples of protein sources being used as animal protein are: eggs, meat, poultry, fish etc.
Intervention code [1] 333158 0
Lifestyle
Intervention code [2] 333746 0
Prevention
Intervention code [3] 334054 0
Behaviour
Description of the comparator or control
Intervention C: Will consume a diet with 30% plant-based and 70% animal-based protein-sources (closely resembling the current dietary protein distribution in Australia). This group will act as the control group.
Control group
Active

Outcomes
Primary outcome [1] 344953 0
Difference in muscle fractional synthesis rates between groups (plant vs animal protein diet)
Timepoint [1] 344953 0
Muscle biopsy: Taken on the first day of the intervention (day 1) and on the day after the intervention ends (day 15) . Blood sample: Taken on the day before the intervention starts (day 0), the first day of the intervention (day 1) and the day after the intervention ends (day 15). Saliva sample: Taken on the day before the intervention starts (day 0) and every day for the following 14 days.
Secondary outcome [1] 459897 0
Difference in metabolic function between groups (plant vs animal diet)
Timepoint [1] 459897 0
Blood samples are taken on the first day (day 1) and on the day after the intervention ends (day 15). CGM will be worn from the first day of the intervention (day 1) and taken off after 1 week (day 7) of the intervention.
Secondary outcome [2] 459898 0
Difference in cardiovascular health between groups (plant vs animal diets)
Timepoint [2] 459898 0
FMD and PWV will be measures on the first day of the intervention (day 1) and the day after the intervention ends (day 15).
Secondary outcome [3] 459899 0
Difference in dietary feasibility between groups
Timepoint [3] 459899 0
The questionnaire will be completed at the last visit. This is the day after they finish the intervention (day 15).
Secondary outcome [4] 459902 0
Dietary compliance between groups
Timepoint [4] 459902 0
A dietary record will be made on day 6, 7 and 8 of the intervention to assess compliance
Secondary outcome [5] 459903 0
Difference in dietary acceptance and sensory experience between groups
Timepoint [5] 459903 0
This questionnaire will be completed at the last visit. This is the day after they finish the intervention (day 15).
Secondary outcome [6] 459905 0
Difference in greenhouse gas emissions of intervention diets.
Timepoint [6] 459905 0
Dietary records are collected at day 6, 7 and 8 of the intervention.
Secondary outcome [7] 459906 0
Difference in biological ageing between groups over time. This outcome is exploratory in nature.
Timepoint [7] 459906 0
Bloods samples are taken on the day before the intervention (day 0) and the day after the intervention ends (day 15). Muscle samples are taken on the first day of the intervention (day 1) and on the day after the intervention ends (day 15)

Eligibility
Key inclusion criteria
The study will include 60 participants, and older adults with an overweight BMI, aged 65 years or more may be eligible to participate.
Minimum age
65 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Participants with one or more of the following will be excluded from being able to participant: diagnosed myopathy, IBS or IBD, diabetes, medicated with immunosuppressant medication, blood thinning medication, blood pressure medication, cholesterol lowering medication, allergy to anaesthesia or living in a care home. Individuals will also be excluded from the study if they do structured resistance exercise more than once a week.

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation will be made by a team member who is not directly involved in the study. The randomisation is made with central randomisation by computer
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer software (i.e. computerised sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s

The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Statistical analysis will be performed using RStudio version 1.4.1106. Descriptive statistics (mean and ±SD) will be performed for baseline characteristics. Between-group comparisons for the feasibility study will be made using mixed linear models adjusted for baseline outcome measures (e.g., Age, gender, physical activity, BMI, initial strength, fat free mass, and physical function). All statistical tests will have a significance set at 95% confidence and p < 0.05.

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 320451 0
University
Name [1] 320451 0
Deakin University
Country [1] 320451 0
Australia
Primary sponsor type
University
Name
Deakin University
Address
Country
Australia
Secondary sponsor category [1] 323065 0
None
Name [1] 323065 0
Address [1] 323065 0
Country [1] 323065 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319003 0
Deakin University Human Research Ethics Committee (DUHREC)
Ethics committee address [1] 319003 0
Ethics committee country [1] 319003 0
Australia
Date submitted for ethics approval [1] 319003 0
29/01/2025
Approval date [1] 319003 0
30/04/2025
Ethics approval number [1] 319003 0
2025/HE000054

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 145942 0
A/Prof Michael Tieland
Address 145942 0
Deakin University, The Institute for Physical Activity and Nutrition, Building J, Michael Tieland, 221, Burwood Hwy, 3125 Burwood, VIC
Country 145942 0
Australia
Phone 145942 0
+61 3 924 68603
Fax 145942 0
Email 145942 0
Contact person for public queries
Name 145943 0
Michael Tieland
Address 145943 0
Deakin University, The Institute for Physical Activity and Nutrition, Building J, Michael Tieland, 221, Burwood Hwy, 3125 Burwood, VIC
Country 145943 0
Australia
Phone 145943 0
+61 3 924 68603
Fax 145943 0
Email 145943 0
Contact person for scientific queries
Name 145944 0
Michael Tieland
Address 145944 0
Deakin University, The Institute for Physical Activity and Nutrition, Building J, Michael Tieland, 221, Burwood Hwy, 3125 Burwood, VIC
Country 145944 0
Australia
Phone 145944 0
+61 3 924 68603
Fax 145944 0
Email 145944 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• All de-identified individual participant data
What types of analyses could be done with individual participant data?
• Studies exploring new research questions
When can requests for individual participant data be made (start and end dates)?
From:
At the end of the study
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.